The Acute Ocular Pain market size is anticipated to increase during the study period (2018-30) in the 7MM

December 16 16:10 2021
The Acute Ocular Pain market size is anticipated to increase during the study period (2018-30) in the 7MM
Acute Ocular Pain Market
The Acute Ocular Pain market dynamics are expected to change during the forecasted period due to the anticipated launch of new therapies.

DelveInsight’s Acute Ocular Pain market report offers detailed information on current treatment practices, emerging drugs, Acute Ocular Pain market share of the individual therapies, current and forecasted Acute Ocular Pain market size from 2018 to 2030 segmented into 7MM (the US, EU5 (the UK, Spain, Germany, Italy, and France), and Japan). 

Some of the Important Findings from the Acute Ocular Pain Market Report

  • As per DelveInsight estimates, the total Acute Ocular Pain cases was over 15 million in the 7MM in 2020. 
  • Among the EU5 countries, Spain had the lowest Acute Ocular Pain cases in 2020.
  • There are several disorders in which patients complain of AOP, but most diseases include Cataract Surgery, Uveitis, Glaucoma Surgery, Corneal Aberrations Surgery, Dry Eye Disease, and Conjunctivitis.
  • Leading players in the Acute Ocular Pain market include Formosa Pharmaceuticals, Sylentis, Aldeyra Therapeutics, and others.
  • Key Acute Ocular Pain therapies in the pipeline include APP13007, Tivanisiran, Reproxalap, and others.
  • Formosa Pharmaceuticals’ APP13007 is a nanoparticle formulation of the corticosteroid clobetasol in development to treat post-operative eye inflammation.
  • The Acute Ocular Pain market size was USD 276.02 million in the 7MM in 2020, which is further anticipated to increase by 2030.

Request for Acute Ocular Pain market report sample to understand more about the emerging drug landscape @ Acute Ocular Pain Market Outlook

Acute Ocular Pain: Overview

Eye pain encompasses a wide range of symptoms, from sharp pain in the eye to mild discomfort or itching in the eyes. Because the spectrum of symptom presentation varies with eye pain, the cause of these pains can range from minor refractive errors to potentially sight-threatening disorders such as glaucoma and uveitis.

Acute Ocular Pain Epidemiology Segmentation

The Acute Ocular Pain report proffers epidemiological analysis for the study period 2018-30 in the 7MM segmented into:

  • Number of Cases of Several Eye Disorders
  • Acute Ocular Pain Number of Cases in Major Eye Disorders

Acute Ocular Pain Treatment Landscape

Pain at the front of the eye caused by surgery, injury, infection, or inflammation is usually treated with a topical steroid, topical NSAID, systemic NSAID, lubricant ointment, gel, or drops, bandage contact lens, or a few doses of oral opiate or topical anesthetic.

Several drugs, including Dextenza, Inveltys, BromSite, and Lotemax, have recently been approved to treat ocular inflammation and pain after ophthalmic and cataract surgery.

Acute Ocular Pain Market Outlook

The Acute Ocular Pain market dynamics are expected to change during the forecasted period due to the anticipated launch of new therapies. APP13007 (Formosa Pharmaceuticals), Tivanisiran (Sylentis), and Reproxalap are the therapies under development to prevent or treat AOP.

Discover more about the future market share of the drugs @ Acute Ocular Pain Market Share

Acute Ocular Pain Pipeline Therapies and Key Companies 

  • APP13007: Formosa Pharmaceuticals
  • Tivanisiran: Sylentis
  • Reproxalap: Aldeyra Therapeutics

Table of Contents 

1.

Key Insights

2.

Report Introduction

3.

Acute Ocular Pain (AOP) Market Overview at a Glance

4.

Executive Summary of Acute Ocular Pain (AOP)

5.

Acute Ocular Pain (AOP) Market: Future Perspective

6.

Epidemiology and Patient Population

7.

Organizations contributing towards Acute Ocular Pain (AOP)

8.

Patient Journey

9.

Marketed Products

10.

Emerging Therapies

11.

Acute Ocular Pain (AOP): Seven Major Market Analysis

12.

KOL Views

13.

Market Drivers

14.

Market Barriers

15.

SWOT Analysis

16.

Unmet Needs

17.

Appendix

18.

DelveInsight Capabilities

19.

Disclaimer

20.

About DelveInsight

Get in touch with our business executive for Healthcare Due Diligence Services

Related Reports

Acute Ocular Pain And Inflammation Market

DelveInsight’s “Acute Ocular Pain And Inflammation- Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Acute Ocular Pain And Inflammation, historical and forecasted epidemiology as well as the Acute Ocular Pain And Inflammation market trends in the 7MM.

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Sandeep Joshi
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: www.delveinsight.com/